Document:

exhibit10-113.htm

EXHIBIT 10-113

 

EXHIBIT B

 

 

   JMJ Financial

San Diego, CA

Miami, FL

                                                                                                                                             

February 22, 2011

Imaging Diagnostic Systems, Inc.

Boca Raton, FL

This letter is to confirm the following regarding A-02222011a:

Authorized Shares.  I am aware that the company is out of authorized shares, and that Section 2.5 of our agreement, Reservation of Shares, will be enforced only after an increase in shares authorized is completed.  By way of the third bullet point on the Funding Schedule, you agree that authorized shares will be increased to 2,000,000,000 in order to allow for shares to be issued for conversion of A-02222011a.

DWAC Electronic Transfer.  The fact that the Company is not currently able to electronically transfer shares via DWAC makes this transaction exceptionally difficult, cumbersome, and risky.  Therefore, you agree that:

	
§  

	
You agree to apply for DWAC electronic transfer within 3 business days of execution of this agreement (at your own expense).

	
§  

	
You agree that as long as the Company is not able to electronically DWAC shares, that JMJ Financial may, at its election, indefinitely stall or cancel (without penalty or liability) any payments described in the Funding Schedule.  Even in the event that JMJ elects to stall any payments, the Company must progress with the registration statement for all payments as set forth in the Funding Schedule (past payments and potential future payments).

 

 

 

/s/ Justin Keener                                                      2-23-2011

JMJ Financial / Its Principal

BORROWER[S]:                                                                           

/s/ Linda B. Grable                                                  2-23-2011

Linda Grable

Chairwoman & CEO

Imaging Diagnostic Systems, Inc.

/s/ Allan L. Schwartz                                               2-23-2011

Allan Schwartz

CFO

Imaging Diagnostic Systems, Inc.exhibit10-114.htm

EXHIBIT 10-114

 

 

EXHIBIT C

REGISTRATION RIGHTS AGREEMENT

Imaging Diagnostic Systems, Inc. (the “Company” or “Borrower”), agrees to provide JMJ Financial (the “Holder” or “Investor”) the following registration rights with respect to Convertible Promissory Note Document A-02222011a (the “Note”).

1. Inducement to Enter Into Transactions.  To induce JMJ Financial to enter into and fund the Note, the Borrower has agreed to provide registration rights for common shares underlying that note.  The Borrower agrees and acknowledges that registration rights are a material inducement for the Holder to enter into this transaction, and that the Holder would not have entered into the transaction if registration of the underlying shares was not provided.

2. Mandatory Registration.  No later than 75 days from the date of execution of this agreement (the “Registration Date”), the Borrower agrees to file an S-1 Registration Statement with the SEC at its own expenses to register 130,000,000 (one hundred thirty million) shares of common stock underlying the note, as follows.  The Borrower will thereafter use its best efforts to cause such Registration  Statement to become  effective as soon as possible after such filing but in no event later than one  hundred  and twenty (120) days from the Registration Date.

Convertible Promissory Note A-02222011a – 130,000,000 shares

Total Note – $1,800,000,000 plus interest

Total Shares to Be Registered – 130,000,000

3. Correspondence and Information.  Within two days of distribution or receipt of any information or correspondence between the Borrower and the SEC, the Borrower shall furnish to Holder copies of all correspondence as related to the registration statement.

4. Assignment of Registration Rights.  The rights under this Agreement  shall be  automatically  assignable by the Holder to any transferee of all or any portion of the note or underlying registered shares.

5. No Filing of Other Registration Statements and No Piggy-back Registrations.  Unless otherwise approved by Holder in Writing, the Borrower shall not file any other registration statements (except for S-8 registration) until the registration statement described herein is declared effective by the SEC;  and the Borrower will not include in this registration statement any securities other than those described herein.

 

  

  

  

 

7. Governing Law. This Note will be governed by, and construed and enforced in accordance, with the laws of the State of Florida, without regard to the conflict of laws principles thereof.  Any action brought by either party against the other concerning the transactions contemplated by this Agreement shall be brought only in the state courts of Florida or in the federal courts located in Miami-Dade County, in the State of Florida.  Both parties and the individuals signing this Agreement agree to submit to the jurisdiction of such courts.

Agreed, this 23rd day of February, 2011.

BORROWER[S]:                                                                           

/s/ Linda B. Grable                                                             2-23-2011

Linda Grable

Chairwoman & CEO

Imaging Diagnostic Systems, Inc.

/s/ Allan L. Schwartz                                                          2-23-2011

Allan Schwartz

CFO

Imaging Diagnostic Systems, Inc.

LENDER/HOLDER:

/s/ Justin Keener                                                                2-23-2011

JMJ Financial / Its PrincipalExhibit 10.1

INDEMNIFICATION AGREEMENT

          THIS
AGREEMENT is made and entered into as of the ____ day of ________________,
200__, by and between ST. JUDE MEDICAL, INC., a Minnesota corporation (the
“Company”), and ____________________________ (“Executive”).

W
I T N E S S E T H :

          WHEREAS,
the Company desires to retain the current and future services of Executive and
to reimburse Executive for personal economic losses of Executive resulting from
the good faith performance of Executive’s duties; and

          WHEREAS,
the indemnification provisions of the Bylaws of the Company are subject to
reduction or elimination at any time without the consent of Executive, and the
Company desires to provide indemnification to Executive to the fullest extent
permitted by law despite any such change in the Bylaws.

          NOW,
THEREFORE, in consideration of the continued services of Executive to the
Company, the Company and Executive agree as follows:

          1.     Indemnification.
The Company agrees to indemnify Executive according to the terms, conditions
and procedures of Exhibit A attached hereto from the date hereof in perpetuity.

          2.     
Amendments to Bylaws. Any amendments to the Bylaws of the Company which
reduce or eliminate indemnification rights of persons thereunder shall have no
effect with respect to this Agreement, and thereafter Executive shall continue
to have all of the rights and benefits of this Agreement despite any such
amendments to the Bylaws. However, if the Bylaws of the Company or the Minnesota
Statutes are amended to provide for greater indemnification rights or
privileges, this Agreement shall not be construed so as to limit Executive’s
rights and privileges to the terms hereof and Executive shall be entitled to
the full benefit of any such additional rights and privileges. Furthermore, to
the extent that the Minnesota Statutes or other applicable law now or hereafter
establishes that indemnification cannot be made by the Company according to
this Agreement in any respect, this Agreement shall be interpreted as being
simultaneously amended to provide indemnification hereunder to the fullest
extent permitted by law.

          3.     
Director and Officer Insurance Coverage. In the event: (a) the Company
determines to materially reduce or not to renew its director and officer
insurance (“D&O Insurance”) coverage, the Company will purchase six year
tail coverage D&O Insurance, on terms and conditions substantially similar
to the existing D&O Insurance (“Comparable Coverage”), for the benefit of
the directors and officers who had served prior to the reduction, termination
or expiration of the coverage (the “Prior Directors and Officers”); or (b) of a
Change of Control (as defined below), the Company will either (A) purchase six
year tail coverage D&O Insurance with Comparable Coverage for the benefit
of the Prior Directors and Officers prior to the closing of the transaction or
the occurrence of the event constituting the Change of Control, or (B) secure
the contractual agreement by the acquiring entity or person to purchase such
coverage and require the acquiring entity or person to deliver proof of the
purchase of such coverage, in form and substance satisfactory to the Company,
at or prior to the closing of the transaction or the occurrence of the event constituting
the Change in Control. Notwithstanding the foregoing, if the annual premium for
any year of such tail coverage would exceed two times the annual premium the
Company paid for D&O Insurance in its last full fiscal year prior to the
reduction, termination or expiration of the D&O Insurance or of a change in
control of the Company, the Company will be deemed to have satisfied its
obligations under this Section by purchasing as much D&O Insurance for such
year as can be obtained for a premium equal to twice the annual premium the
Company paid for D&O Insurance in its last full fiscal year.

          For
purposes of this Agreement, a “Change in Control” means any transaction or
event or series of related transactions or events which result in (a) a consolidation,
merger or other combination of the Company and another entity as a result of
which one or more entities or persons acquires or for the first time controls
or is able to vote (directly or through nominees or beneficial ownership) more
than 15% of any class of stock of the Company, (b) any person or
group becoming the “beneficial owner” (as defined in Rule 13d-3 of the
Securities Exchange Act of 1934), directly or indirectly, of voting securities
of the Company representing 15% or more of the total voting power represented
by Buyer’s then outstanding voting securities, (c) a sale, conveyance,
exclusive license or disposition of all or substantially all of the Company’s
assets, (d) the directors immediately prior to the first of such transactions
or events failing to constitute a majority of the board of directors of the
Company, or (e) the filing by the Company of a petition for protection under
bankruptcy or similar debtor-relief laws, or the Company being the subject of
an involuntary petition by creditors for similar action. 

          4.     
Third Party Beneficiaries. Each of the directors and officers of the
Company from time to time is hereby made a third party beneficiary of this
Agreement.

          5.     
Remedies. The Company acknowledges that money damages would be an
inadequate remedy for any breach of its obligations under this Agreement.
Accordingly, Executive or any third party beneficiary under this Agreement
shall be entitled to specific performance, injunctive relief or other equitable
remedies in any court of competent jurisdiction in addition to any other remedy
at law in the event of a material breach, or threatened material breach, of
this Agreement by the Company, without the necessity of proving either actual
damages or the inadequacy of money damages, or posting bond. In the event of
any legal action or proceeding seeking enforcement of this Agreement, Executive
or any third party beneficiary hereunder shall also be entitled to recover his
or her reasonable attorney’s fees and costs incurred in connection with such
action or proceeding.

          6.     
 Successors and Assigns. This
Agreement shall be binding upon and shall inure to any and all successors,
assigns, heirs, estates, representatives and administrators of the parties hereto.

          7.     
No Amendments. This Agreement may not be amended, modified or
terminated, except by the express written consent thereto by both parties
hereto.

          8.     
Other Agreements. This Agreement is supplementary to and not exclusive
of other agreements between the Company and Executive which may exist now or in
the future to the extent such agreements are not inconsistent herewith.

          9.     Survival.
The rights of Executive under this Agreement shall survive and continue in
effect after the termination of services to the Company by Executive, whether
by death, retirement or otherwise.

          10.     Savings.
If any provision or application of this Agreement is held unlawful or
unenforceable in any respect, such illegality or unenforceability shall not
affect other provisions or applications which can be given effect, and this
Agreement shall be construed as if the unlawful or unenforceable provision or
application had never been contained herein or prescribed hereby.

          11.     Governing
Law. This Agreement shall be interpreted and governed by the laws of the
State of Minnesota.

          IN
WITNESS WHEREOF, the undersigned parties have executed this Agreement as of the
date set forth above.

	
  

 	
  

 	
  

 
	
  

 	
  

 	
  

 
	
  

 	
 ST. JUDE MEDICAL, INC.

 
	
  

 	
  

 	
  

 
	
  

 	
 By:

 	 

 
	
  

 	
  

 	
           Daniel
 J. Starks

 
	
  

 	
  

 	
           President
 and Chief Executive Officer

 
	
  

 	
  

 	
  

 
	
  

 	
 EXECUTIVE

 

	
  

 	
  

 	
  

 
	
  

 	
 By:

 	 

 
	
  

 	
  

 	
 [Insert
 name]

 

2

EXHIBIT A

Indemnification

          Section
1.           Definitions.

          (a)          For
purposes of this Exhibit the terms defined in this Section have the meanings
given them.

          (b)          “Corporation”
includes St. Jude Medical, Inc. and a domestic or foreign Corporation that was
the predecessor of St. Jude Medical, Inc. in a merger or other transaction in
which the predecessor’s existence ceased upon consummation of the transaction.

          (c)          “Official
Capacity” means (1) with respect to a director, the position of director in the
Corporation, (2) with respect to a person other than a director, the elective
or appointive office or position held by an officer or member of a committee of
the Board, or the employment or agency relationship undertaken by an employee
or agent of the Corporation, (3) with respect to a director, officer, employee
or agent of the Corporation who, while a director, officer, employee or agent
of the Corporation, is or was serving at the request of the Corporation or
whose duties in that position involve or involved service as a director,
officer, partner, trustee, or agent of another organization or employee benefit
plan, the position of that person as a director, officer, partner, trustee,
employee or agent, as the case may be, of the other organization or employee
benefit plan.

          (d)          “Proceeding”
means a threatened, pending or completed civil, criminal, administrative,
arbitration or investigative proceeding, including a proceeding by or in the
right of the Corporation.

          (e)          “Special
Legal Counsel” means counsel who has not represented the Corporation or related
corporation, or a director, officer, employee or agent whose indemnification is
in issue.

          Section
2.          Indemnification
Mandatory; Standard.

          (a)          Subject
to the provisions of Section 5, the Corporation shall indemnify a person made
or threatened to be made a party to a Proceeding by reason of the former or
present Official Capacity of the person against judgments, penalties, fines,
including, without limitation, excise taxes assessed against the person with
respect to an employee benefit plan, settlements and reasonable expenses,
including attorneys’ fees and disbursements, incurred by the person in
connection with the Proceeding, if, with respect to the acts or omissions of
the person complained of in the Proceeding, the person:

	
  

 	
  

 
	
  

 	
           (1)          has
 not been indemnified by another organization or employee benefit plan for the
 same judgments, penalties, fines, including, without limitation, excise taxes
 assessed against the person with respect to an employee benefit plan,
 settlements, and reasonable expenses, including attorneys’ fees and
 disbursements, incurred by the person in connection with the Proceeding with
 respect to the same acts or omissions;

 
	
  

 	
  

 
	
  

 	
           (2)          acted
 in good faith;

 
	
  

 	
  

 
	
  

 	
           (3)          received
 no improper personal benefit and Minnesota Statutes, Section 302A.255, if
 applicable, has been satisfied;

 
	
  

 	
  

 
	
  

 	
           (4)          in
 the case of a criminal Proceeding, had no reasonable cause to believe the
 conduct was unlawful; and

 

	
  

 	
  

 
	
  

 	
  

 
	
  

 	
           (5)          in
 the case of acts or omissions occurring in the Official Capacity described in
 Section 1, paragraph (c), clause (1) or (2), reasonably believed that the
 conduct was in the best interests of the Corporation, or in the case of acts
 or omissions occurring in the Official Capacity described in Section 1,
 paragraph (c), clause (3), reasonably believed that the conduct was not
 opposed to the best interests of the Corporation. If the person’s acts or
 omissions complained of in the Proceeding relate to conduct as a director,
 officer, trustee, employee or agent of an employee benefit plan, the conduct
 is not considered to be opposed to the best interests of the Corporation if
 the person reasonably believed that the conduct was in the best interests of
 the participants or beneficiaries of the employee benefit plan.

 

          (b)          The
termination of a Proceeding by judgment, order, settlement, conviction or upon
a plea of nolo contendere or its equivalent does not, of itself, establish that
the person did not meet the criteria set forth in this Section 2.

          Section
3.          Advances.
Subject to the provisions of Section 5, if a person is made or threatened to be
made a party to a Proceeding, the person is entitled, upon written request to
the Corporation, to payment or reimbursement by the Corporation of reasonable
expenses, including attorneys’ fees and disbursements, incurred by the person
in advance of the final disposition of the Proceeding, (a) upon receipt by the
Corporation of a written affirmation by the person of a good faith belief that
the criteria for indemnification set forth in Section 2 have been satisfied and
a written undertaking by the person to repay all amounts so paid or reimbursed
by the Corporation, if it is ultimately determined that the criteria for
indemnification have not been satisfied, and (b) after a determination that the
facts then known to those making the determination would not preclude
indemnification under this Exhibit. The written undertaking required by clause
(a) is an unlimited general obligation of the person making it, but need not be
secured and shall be accepted without reference to financial ability to make
the repayment.

          Section
4.          Reimbursement
to Witness. The Corporation shall reimburse expenses, including attorneys’
fees and disbursements, incurred by a person in connection with an appearance
as a witness in a Proceeding at a time when the person has not been made or
threatened to be made a party to a Proceeding.

          Section
5.          Determination
of eligibility.

          (a)
All determinations whether indemnification of a person is required because the
criteria set forth in Section 2 have been satisfied and whether a person is
entitled to payment or reimbursement of expenses in advance of the final
disposition of a Proceeding as provided in Section 3 shall be made:

	
  

 	
  

 
	
  

 	
           (1)          by
 the Board by a majority of a quorum. Directors who are at the time parties to
 the Proceeding shall not be counted for determining either a majority or the
 presence of a quorum;

 
	
  

 	
  

 
	
  

 	
           (2)          if
 a quorum under clause (1) cannot be obtained, by a majority of a committee of
 the Board, consisting solely of two or more directors not at the time parties
 to the Proceeding, duly designated to act in the matter by a majority of the
 full Board including directors who are parties;

 
	
  

 	
  

 
	
  

 	
           (3)          if
 a determination is not made under clause (1) or (2), by Special Legal
 Counsel, selected either by a majority of the Board or a committee by vote
 pursuant to clause (1) or (2) or, if the requisite quorum of the full Board
 cannot be obtained and the committee cannot be established, by a majority of
 the full Board including directors who are parties;

 
	
  

 	
  

 
	
  

 	
           (4)          if
 a determination is not made under clauses (1) to (3), by the shareholders,
 excluding the votes of shares held by parties to the Proceeding; or

 
	
  

 	
  

 
	
  

 	
           (5)          if
 an adverse determination is made under clauses (1) to (4) or under paragraph
 (b), or if no determination is made under clauses (1) to (4) or under
 paragraph (b) within 60 days after the termination of a Proceeding or after a
 request for an advance of expenses, as the case may be, by a court in this
 state, which may be the same court in which the Proceeding involving the
 person’s liability took place, upon application of the person and any notice
 the court requires.

 

          (b)          With
respect to a person who is not, and was not at the time of the acts or
omissions complained of in the Proceeding, a director, officer or person
possessing, directly or indirectly, the power to direct or cause the direction
of the management or policies of the Corporation, the determination whether
indemnification of this person is required because the criteria set forth in
Section 2 have been satisfied and whether this person is entitled to payment or
reimbursement of expenses in advance of the final disposition of a Proceeding
as provided in Section 3 may be made by an annually appointed committee of the
Board, having at least one member who is a director. The committee shall report
at least annually to the Board concerning its actions.

 2

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00185-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00185-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00185-of-00352.parquet"}]]